In the latest trading session, 0.52 million ZyVersa Therapeutics Inc (NASDAQ:ZVSA) shares changed hands as the company’s beta touched 0.25. With the company’s most recent per share price at $1.49 changing hands around $0.02 or 1.02% at last look, the market valuation stands at $3.73M. ZVSA’s current price is a discount, trading about -1577.85% off its 52-week high of $25.00. The share price had its 52-week low at $0.98, which suggests the last value was 34.23% up since then. When we look at ZyVersa Therapeutics Inc’s average trading volume, we note the 10-day average is 3.91 million shares, with the 3-month average coming to 1.93 million.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Instantly ZVSA is in green as seen in intraday trades today. With action 19.76%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 40.09%, with the 5-day performance at 19.76% in the green. However, in the 30-day time frame, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) is 30.33% up. Looking at the short shares, we see there were 45485.0 shares sold at short interest cover period of 0.19 days.
ZyVersa Therapeutics Inc (ZVSA) estimates and forecasts
Data shows that the ZyVersa Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -69.69% over the past 6 months, a 97.65% in annual growth rate that is considerably higher than the industry average of 16.40%.
The 2025 estimates are for ZyVersa Therapeutics Inc earnings to increase by 98.86%.
ZVSA Dividends
ZyVersa Therapeutics Inc is expected to release its next quarterly earnings report in February.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.61% of ZyVersa Therapeutics Inc shares while 4.47% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.50%.
Among Mutual Funds, the top two as of Nov 30, 2024 were Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund. With 4.95 shares estimated at $7427.0 under it, the former controlled 0.20% of total outstanding shares. On the other hand, Fidelity Series Total Market Index Fund held about 0.06% of the shares, roughly 1.39 shares worth around $2091.0.
